NCT02993614 Comparative Effectiveness of Cardiovascular Outcomes in New Users of SGLT-2 Inhibitors Status COMPLETED Phase N/A
NCT02991274 ARTEMIS DIANE T790M (An Amino Acid Substitution at Position 790 in EGFR, From a Threonine (T) to a Methionine (M)) Mutation at Hospital Laboratories in Comparison With Central Laboratory Status COMPLETED Phase N/A
NCT02988141 EGFR-TKI Resistance Profile in Chinese Patients With Advanced EGFRm+ NSCLC Status UNKNOWN Phase N/A
NCT02988011 Improving Glucose and Lipid Metabolism Through Caloric Restriction Using Diet or Surgery (CRUDOS) Status UNKNOWN Phase NA
NCT02987738 Pilot Study to Explore the Efficacy of DAPAglifozin as add-on to Closed-loop Control in Patients With Type 1 Diabetes Status COMPLETED Phase PHASE1
NCT02987543 Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study) Status COMPLETED Phase PHASE3
NCT02984423 FLABRA: Frontline Approach for BRCA Testing in OC Treatment naïve Population. A LATIN AMERICA Epidemiologic Study Status COMPLETED Phase N/A
NCT02983799 Olaparib Tablets as a Treatment for Ovarian Cancer Subjects With Different HRD Tumor Status Status COMPLETED Phase PHASE2
NCT02983578 Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02981966 Effect of Dapagliflozin on Hepatic and Renal Glucose Metabolism Subjects Status COMPLETED Phase PHASE4
NCT02981069 Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DM Status COMPLETED Phase PHASE4
NCT02978482 A Phase 1/2 Study of Durvalumab(MEDI4736) and Tremelimumab in Chinese Patients With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT02976831 Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD0284 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02974244 Comparison of the Effectiveness and Tolerability of Exenatide Once-weekly Compared to Basal Insulins Status COMPLETED Phase N/A
NCT02973477 Dapagliflozin and Measures of Cardiovascular Autonomic Function in Patients With Type 2 Diabetes (T2D) Status COMPLETED Phase PHASE4
NCT02972840 A Study of BR Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated MCL Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02972658 A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia Status TERMINATED Phase PHASE3
NCT02972476 Microbiome Use to Stratify Use of Inhaled Corticosteroids: MUSIC Trial Status COMPLETED Phase PHASE4